Dr. Okere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1820 Route 33
Suite 4B
Neptune, NJ 07753Phone+1 732-776-8500Fax+1 732-776-8946
Education & Training
- Stony Brook Medicine/University HospitalFellowship, Interventional Cardiology, 2014 - 2015
- Icahn School of Medicine at Mount Sinai/Beth Israel/WestFellowship, Cardiovascular Disease, 2011 - 2014
- NYU Grossman School of MedicineResidency, Internal Medicine, 2007 - 2010
- Boston University School of MedicineClass of 2007
- Cornell UniversityB.A., Biological Sciences, 1997 - 2001
Certifications & Licensure
- NY State Medical License 2010 - Present
- NJ State Medical License 2015 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Alliance for Physician Certification and Advancement (APCA)Nuclear Cardiology
- Alliance for Physician Certification and Advancement (APCA)Registered Physician in Vascular Interpretation (RPVI)
- National Board of EchocardiographyAdult Comprehensive Echocardiography
Awards, Honors, & Recognition
- Nurse's Choice Physician of the Year Award Ocean University Medical Center, 2022
- Top Doctor 2020 NJ TopDocs, 2020
- Teacher of the Year Award Ocean University Medical Center Internal Medicine Residency Program, 2020
- Join now to see all
Clinical Trials
- IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction Start of enrollment: 2012 Apr 01
- XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. Start of enrollment: 2017 Jul 19
- National Cardiogenic Shock Initiative Start of enrollment: 2016 May 19
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsSymptomatic Myocarditis Post COVID-19 Vaccination.Palak Patel, Dhaval Desai, Nagapratap Ganta, Satish Tadepalli, Priyaranjan Kata
Cureus. 2022-04-01 - 14 citationsA Cardiomyopathy in a Patient With Limb Girdle Muscular Dystrophy Type 2AArthur Okere, Sesha S. Reddy, Sheila Gupta, Meir Shinnar
Circulation. Heart Failure. 2013-01-01 - 3 citationsRecognizing Rare Sequelae of Epstein-Barr Virus Myocarditis Leading to Dilated Cardiomyopathy and Acute Congestive Heart Failure With Multivalvular Regurgitation.Mina Aknouk, Suhrim Choe, Harmony Osborn, Anish Kanukuntla, Priyaranjan Kata
Cureus. 2022-01-01
Journal Articles
- Racial Differences in Radial Artery Diameter in a Population Undergoing Coronary AngiographyOkere A, Zhou X, Huang Y, Dogan O, Rodriguez C, Tejani F, Daggubati R, Nanjundappa A, Kwan T., Experimental and Clinical Cardiology, 2/20/2014
Abstracts/Posters
- Prevalence and Outcomes of Cardiac Arrest Amongst Patients with Takotsubo Syndrome Hospitalizations: A Nationwide Inpatient Cohort AnalysisNair A, Uddin M, Patel H, Thakkar S, Alweis R, Patel B, Evbayekha E, Okorare O, Pandya K, Badu I, Dandu S, Hegde S, Dani S, Okere A, Kassi M, Feitell S, ACC 24: American College of Cardiology 73rd Annual Scientific Sessions, Atlanta, GA, 4/2024
- Predictors and Outcomes of ECMO in Patients with ThrombocytosisZonshayn D, Nair A, Bolaji O, Deen Z, Okere A, ACPNJ 24: American College of Physicians New Jersey Annual Scientific Sessions, Princeton, NJ, 3/2024
- A Complicated Case of Triple Valve Endocarditis with Emboli Successfully Treated with SurgeryMazahir U, Obaji A, Okere A, Simsir S, ACC 19: American College of Cardiology Scientific Sessions, New Orleans, LA, 3/18/2019
- Join now to see all
Lectures
- "Overview of Cardiogenic Shock"Lecture Series, Department of Cardiology, Ocean University Medical Center, Brick, NJ - 3/2024
- “The SFA: Improving Patency in Lower Extremity Arterial Disease”Grand Rounds, Division of Cardiology, Mount Sinai Beth Israel Medical Center, New York, NY - 6/2013
- “Cardiotoxicity of Chemotherapy”Grand Rounds, Division of Cardiology, Mount Sinai Beth Israel Medical Center, New York, NY - 3/2012
Other
- Severe Invasive Group A Streptococcal Disease with Rhabdomyolysis but Without Evidence Of Shock or Local MyositisOkere A, Schwartz D, Tierno P, Schlievert P, Hamadeh R., Scholarly Research Exchange
http://www.hindawi.com/archive/2009/786451/abs/
Press Mentions
- IM Residents accepted to Fellowship ProgramsJanuary 18th, 2022
- Nurses Choice Physician of the Year Awards to be Announced March 30!March 25th, 2022
- Emergency, Coordinated Heart Care Rescues Busy ProfessionalSeptember 17th, 2024
- Join now to see all
Committees
- Member, Clinical and Academic Leadership Committee (CALC): Ocean University Medical Center 2022 - Present
- Heart Failure Champion, Heart Failure Committee: Ocean University Medical Center 2021 - Present
- Committee Representative: Attending Interventional Cardiologist, ACS Committee: Ocean University Medical Center 2015 - Present
- Committee Representative: Interventional Cardiology, ED Door-to-Balloon Committee: Stony Brook University Medical Center 2014 - 2015
- Committee Representative: Cardiovascular Disease, House Staff Committee Representative: Mount Sinai Beth Israel Medical Center 2012 - 2014
Research History
- Sub-Investigator, Jersey Shore University Medical CenterNational Cardiogenic Shock Initiative (NCSI): A prospective cohort study to evaluate the use of early mechanical circulatory support in patients presenting with acute myocardial infarction and cardiogenic shock.2019 - 2022
- Sub-Investigator, Jersey Shore University Medical CenterXIENCE 28 USA Study: A prospective, single arm, multi-center, open label, non-randomized trial to evaluate safety of 1-month (as short as 28 days) dual antiplatelet therapy (DAPT) in subjects at high risk of bleeding undergoing PCI with the approved XIENCE family of coronary drug-eluting stents.2019 - 2020
- Sub-Investigator, Jersey Shore University Medical CenterXIENCE Short DAPT Study: A prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with any approved XIENCE family of Stent Systems.2017 - 2020
- Sub-Investigator, Stony Brook University Medical CenterPRESERVATION I Trial: A placebo-controlled, multicenter, randomized, double blind trial to evaluate the safety and effectiveness of IK-5001 for the prevention of remodeling of the ventricle and congestive heart failure after acute myocardial infarction.2014 - 2019
- Research Fellow, Boston University School of MedicineInvestigating the Translational and Post-Translational Regulation of Cellular Glutathione Peroxidase, GPX-1: Implications in Homocysteine Metabolism2002 - 2003
- Research Fellow, Massachussetts General HospitalExamining the Stem Cell Capacity of the GATA-1-GFP Hematopoietic Progenitor Cell: Targeting progenitor cells with a transgenic mouse model2001 - 2002
Professional Memberships
- Fellow
- Member
- Society for Cardiovascular Angiography and Interventions - SCAIMember
- Association of Black Cardiologists - ABCMember
External Links
- Shore Heart Grouphttp://www.shoreheartgroup.com/
- LinkedInhttps://www.linkedin.com/in/arthur-okere-md-facc-fscai-1a2a9b44/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: